Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...

Researchers at Australia's WEHI (Walter and Eliza Hall Institute) medical research center applied AI analysis to over 50,000 ...

Most people living with MS will undergo a certain amount of disease progression. To help determine your personal outlook, it helps to understand the risk factors that may indicate a greater chance ...

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

The following is a summary of “Neurofilament heavy chain in secondary progressive multiple sclerosis,” published in the January 2025 issue of Neurology by Angelis et al. Biomarkers are essential for ...

Background Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

There is a much greater need for new therapies for progressive forms of MS than for relapsing forms of the disease. While relapsing forms are characterised by sudden attacks associated with ...